BRIEF published on 07/24/2024 at 12:35, 1 year 4 months ago Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement Merger Financing Nasdaq Biopharmaceutical QTORIN™
PRESS RELEASE published on 07/24/2024 at 12:30, 1 year 4 months ago Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement Palvella Therapeutics, Inc. and Pieris Pharmaceuticals, Inc. announce a merger to focus on rare genetic skin diseases with QTORIN™ rapamycin. Joint webcast on July 24 at 8:30am ET Merger Clinical-stage Genetic Skin Diseases QTORIN™ Rapamycin FDA-approved Therapies
BRIEF published on 04/19/2024 at 18:15, 1 year 7 months ago Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split Reverse Stock Split Nasdaq Compliance Financial Regulation Pieris Pharmaceuticals Stock Adjustment
PRESS RELEASE published on 04/19/2024 at 18:10, 1 year 7 months ago Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split Pieris Pharmaceuticals, Inc. announces a 1-for-80 reverse stock split effective on April 22, 2024, to comply with Nasdaq listing requirements. No fractional shares will be issued Reverse Stock Split Compliance Nasdaq Pieris Pharmaceuticals Stockholder Ownership
BRIEF published on 03/27/2024 at 13:05, 1 year 8 months ago Pieris Pharmaceuticals Announces New Strategy to Maximize Financial Potential Shareholder Value Pieris Pharmaceuticals Strategic Reorganization Milestone Payments Royalty Potential
PRESS RELEASE published on 03/27/2024 at 13:00, 1 year 8 months ago Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential Pieris Pharmaceuticals, Inc. announces strategic repositioning to maximize milestone and royalty potential from immuno-oncology assets. Cost-saving measures extend cash runway into 2027 Strategic Repositioning Cost-saving Measures Pieris Pharmaceuticals Milestone Payments Immuno-oncology Assets
Published on 12/15/2025 at 18:15, 1 hour 50 minutes ago Athena Gold Closes Second Tranche of Non-brokered Private Placement and Increases Offering Due to Strong Demand
Published on 12/15/2025 at 16:35, 3 hours 30 minutes ago Stillwater Critical Minerals Announces Upsize of Bought Deal LIFE Private Placement for Gross Proceeds of C$15 Million
Published on 12/15/2025 at 15:00, 5 hours 5 minutes ago Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 5 hours 5 minutes ago Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 5 hours 35 minutes ago Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix
Published on 12/15/2025 at 19:58, 6 minutes ago EQS-Adhoc: AdCapital AG: Sale of KTS Kunststoff Technik Schmölln GmbH in line with “Vision 2030” strategy
Published on 12/15/2025 at 18:15, 1 hour 50 minutes ago Results of EQT’s mandatory simplified cash tender offer for Waga Energy’s remaining shares
Published on 12/15/2025 at 18:00, 2 hours 4 minutes ago LIGHTON: Adjustment of ARR target for FY 2025
Published on 12/15/2025 at 17:45, 2 hours 19 minutes ago EQS-Adhoc: Airbus SE: Airbus reports share buybacks for week starting 8 December 2025
Published on 12/15/2025 at 18:30, 1 hour 35 minutes ago MCH PRIVATE EQUITY AND EURAZEO ENTER INTO AN EXCLUSIVE AGREEMENT WITH ARDIAN FOR THE SALE OF THEIR MAJORITY STAKE IN FERMAX
Published on 12/15/2025 at 18:05, 2 hours ago Covivio - Treasury shares transactions between December 8th , 2025 and December 12th, 2025
Published on 12/15/2025 at 17:45, 2 hours 19 minutes ago ENGIE strengthens the resilience of the Belgian electricity system with new flexible capacities
Published on 12/15/2025 at 17:40, 2 hours 25 minutes ago LISI joins the SBF 120 and CAC Mid 60 indices
Published on 12/15/2025 at 17:35, 2 hours 30 minutes ago DISCLOSURE OF TRANSACTIONS IN OWN SHARES FROM DECEMBER 8 TO DECEMBER 12, 2025
